Jamali Marzieh, Bakhtiyari Mahmood, Arab Fatemeh, Mirzamoradi Masoumeh
Medical student, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Community Medicine, Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Obstet Gynecol Sci. 2020 May;63(3):323-329. doi: 10.5468/ogs.2020.63.3.323. Epub 2020 Apr 21.
This study aims to investigate the complications due to misoprostol administration for second-trimester termination of pregnancy among women with history of 2 or more cesarean scarring.
The cohort of this retrospective study included 678 subjects who required second-trimester pregnancy termination, from 2013 to 2015 and treated with vaginal misoprostol of 100 to 400 µg. The subjects were divided into 3 groups based on their history of cesarean sections: without a history of cesarean section, with a history of one cesarean section, and with a history of more than one cesarean section and uterine scaring.
The results showed that the success rate of misoprostol administration for pregnancy termination was 95.72%. The rate of bleeding as a complication was significantly higher in subjects with a history of more than one cesarean section than in other participants (risk ratio [RR], 2.24; 95% confidence interval [CI], 1.11-4.0). The incidence of uterine rupture was higher in the group with a history of more than one cesarean section than in other groups. However, no significant difference was observed between the groups (RR, 1.44; 95% CI, 0.27-7.6). There was a significant relationship between the need for other auxiliary treatments in the pregnancy termination and the history of uterine scarring (RR, 3.3; 95% CI, 1.23-9.1).
The present study showed that pregnancy termination using smaller divided dose of misoprostol in patients with previous history of cesarean scarring may be associated with lower incidence of uterine rupture.
本研究旨在调查有2次或更多次剖宫产瘢痕史的女性在孕中期使用米索前列醇终止妊娠的并发症。
这项回顾性研究的队列包括2013年至2015年期间678名需要孕中期终止妊娠并接受100至400μg阴道米索前列醇治疗的受试者。根据剖宫产史将受试者分为3组:无剖宫产史、有1次剖宫产史、有1次以上剖宫产史且子宫有瘢痕。
结果显示,米索前列醇用于终止妊娠的成功率为95.72%。有1次以上剖宫产史的受试者作为并发症的出血率显著高于其他受试者(风险比[RR],2.24;95%置信区间[CI],1.11 - 4.0)。有1次以上剖宫产史的组子宫破裂发生率高于其他组。然而,各组之间未观察到显著差异(RR,1.44;95% CI,0.27 - 7.6)。终止妊娠时需要其他辅助治疗与子宫瘢痕史之间存在显著关系(RR,3.3;95% CI,1.23 - 9.1)。
本研究表明,有剖宫产瘢痕史的患者使用较小剂量分次服用的米索前列醇终止妊娠可能与较低的子宫破裂发生率相关。